|
|
|
|
|
CUSIP No. 140755109
|
|
SCHEDULE 13G/A
|
|
Page 4 of 6 Pages
|
Preliminary Note
This Amendment No. 1 (this Amendment), amends and supplements the Schedule 13G (the Schedule 13G)
initially filed with the Securities and Exchange Commission (the SEC) on October 23, 2020 by each of Vifor (International) Ltd., an entity formed under the laws of Switzerland (Vifor (International)), Vifor
Fresenius Medical Care Renal Pharma Ltd., an entity formed under the laws of Switzerland (VFMCRP and, together with Vifor (International), Investors), and Vifor Pharma Ltd., an entity formed under the laws of
Switzerland (Vifor Pharma and, together with Investors, the Reporting Persons), relating to the shares of common stock, par value $0.001 per share (Common Stock), of Cara Therapeutics, Inc., a
Delaware corporation (the Issuer). Capitalized terms used in this Amendment and not otherwise defined herein shall have the same meanings ascribed to them in the Schedule 13G. Except as otherwise provided herein, each Item of the
Schedule 13G remains unchanged.
Item 4 is hereby amended and restated in its entirety to read as follows:
(a) Amount beneficially owned:
(b) Percent of class:
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
(ii) Shared power to vote or to direct the vote:
(iii) Sole power to dispose or to direct the disposition of:
(iv) Shared power to dispose or to direct the disposition of:
As of October 20, 2021, the Reporting Persons respective beneficial ownership was as follows:
(A) Vifor (International) Ltd.
Amount beneficially owned: 7,396,770 shares
Percent of class: 13.9%
Sole voting power: 0
shares Shared voting power: 7,396,770 shares
Sole dispositive power: 0 shares
Shared dispositive power: 7,396,770 shares
(B) Vifor Fresenius Medical Care Renal Pharma Ltd.
Amount beneficially owned: 6,221,943 shares
Percent of class: 11.7%
Sole voting power: 0 shares
Shared voting power: 0 shares
Sole dispositive power: 0 shares
Shared dispositive power: 0 shares
(C) Vifor Pharma Ltd.
Amount beneficially owned: 7,396,770 shares
Percent of class: 13.9%
Sole voting power: 0 shares
Shared voting power: 7,396,770 shares
Sole dispositive power: 0 shares
Shared dispositive power: 7,396,770 shares
Vifor Fresenius Medical Care Renal Pharma Ltd.s beneficial ownership of the common stock referred to herein is being
reported solely because Vifor Fresenius Medical Care Renal Pharma Ltd. may be deemed to beneficially own such shares as a result of its right to acquire such shares upon exercise of an option granted to it by Vifor (International) Ltd. Vifor Pharma
Ltd.s beneficial ownership of the common stock referred to herein is being reported solely because Vifor Pharma Ltd. may be deemed to beneficially own such shares as a result of its indirect ownership of 100% of the equity interests of Vifor
(International) Ltd. and 55% of the equity interests of Vifor Fresenius Medical Care Renal Pharma Ltd. Neither the filing of